ALKBH5‐Mediated M 6 A Demethylation of G3BP1 Attenuates Ferroptosis Via Cytoplasmic Retention of YBX1/p53 in Diabetic Myocardial Ischemia‐Reperfusion Injury
Advanced Science · 2025-09 · 12 (35)
DOI: 10.1002/advs.202507254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.06.2025. Verfasst von Wenyuan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Y-Box-Binding Protein 1, Ferroptosis, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing iGandan Foundation, Natural Science Foundation of Yichang Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
The overexpression of ALKBH5 alleviates damage to cardiomyocytes and tissues, decreases the expression of SLC7A11, and inhibits the expression of p53 N/T and ferroptosis. ALKBH5 induces ferroptosis in the HH/R model by mutating the 3′‐UTR of G3BP1 mRNA and m 6 A sites at positions 142 and 173. Mutations of sites 142 and 173 only partially affect the levels of p53 N/T , SLC7A11 and ferroptosis. G3BP1, YBX1 and p53 protein can bind to each other, and p53 can inhibit the expression of SLC7A11 via nuclear binding to the promoter region of SLC7A11 mRNA. The p53 and YBX1 proteins can synergistically enter the nucleus to aggravate cell damage, while G3BP1 is expressed in the cytoplasm and inhibits p53 binding to SLC7A11 by blocking the entry of the p53 and YBX1 proteins into the nucleus. ALKBH5 promotes G3BP1 expression through m 6 A methylation at m 6 A sites 142 and 173. Subsequently, G3BP1, YBX1, and p53 interact with each other, the amount of synergistic nuclear translocation of YBX1 and p53 is reduced, and the level of p53 nuclear translocation that inhibiting SLC7A11 transcription is decreased, thereby inhibits cardiomyocyte ferroptosis and reducing myocardial tissue damage during myocardial IRI in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
- Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
ORCID-Profile: Yao Wang
Förderung
- Beijing iGandan Foundation
- Natural Science Foundation of Yichang Municipality
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Li, W., Leng, Y., Xu, H., Xia, Z., & Wang, Y. (2025). ALKBH5‐Mediated M 6 A Demethylation of G3BP1 Attenuates Ferroptosis Via Cytoplasmic Retention of YBX1/p53 in Diabetic Myocardial Ischemia‐Reperfusion Injury. Advanced Science, 12(35). https://doi.org/10.1002/advs.202507254
Vancouver
Li W, Li W, Leng Y, Xu H, Xia Z, Wang Y. ALKBH5‐Mediated M 6 A Demethylation of G3BP1 Attenuates Ferroptosis Via Cytoplasmic Retention of YBX1/p53 in Diabetic Myocardial Ischemia‐Reperfusion Injury. Advanced Science. 2025;12(35). doi:10.1002/advs.202507254
BibTeX
@article{Li2025,
author = {Li, Wenyuan and Li, Wei and Leng, Yan and Xu, Heng and Xia, Zhongyuan and Wang, Yao},
title = {ALKBH5‐Mediated M 6 A Demethylation of G3BP1 Attenuates Ferroptosis Via Cytoplasmic Retention of YBX1/p53 in Diabetic Myocardial Ischemia‐Reperfusion Injury},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {35},
doi = {10.1002/advs.202507254}
}
EUVIMED